President Trump is reportedly planning to announce new drug pricing deals with nearly a dozen drugmakers, a move that extends the administration's effort to link U.S. drug prices to lower prices paid in other countries.
Key facts
- Trump is reportedly planning to announce new drug pricing deals with nearly a dozen drugmakers, according to CNBC.
- CNBC reported that Trump struck new drug pricing deals with nine midsized drugmakers.
- The deals build on the administration's push to link U.S. drug prices to cheaper prices abroad.
- The reports were published by CNBC on August 31, 2026.
President Donald Trump is reportedly preparing to announce new drug pricing deals with nearly a dozen drugmakers, according to CNBC. The reporting frames the move as part of a broader effort by the administration to bring down what Americans pay for prescription medicines.
In an updated report published later the same day, CNBC said Trump struck new drug pricing deals with nine midsized drugmakers. The outlet described the agreements as part of a string of deals rather than a single announcement.
According to CNBC, the deals build on the Trump administration’s push to link the nation’s drug prices to cheaper ones abroad. That approach seeks to tie the prices paid in the United States to lower prices charged in other countries.
The available reporting does not specify which drugmakers are involved, the medicines covered, or the financial terms of the agreements. It also does not detail a timeline for when the reported deals would take effect.
CNBC’s coverage indicates the agreements form part of an ongoing series of deals rather than a one-off measure, suggesting the administration is pursuing arrangements with multiple companies over time.
Why it matters
Drug prices are a persistent concern for American consumers, and policies that link U.S. costs to lower prices abroad could affect what patients pay at the pharmacy. Deals with multiple drugmakers signal a coordinated federal effort that could reshape how prescription medicines are priced.
Frequently asked questions
How many drugmakers are involved in the reported deals?
CNBC reported that Trump is planning to announce deals with nearly a dozen drugmakers, and in a later report said he struck deals with nine midsized drugmakers.
What is the goal of these drug pricing deals?
According to CNBC, the deals build on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.
When were these reports published?
CNBC published its reports on August 31, 2026.